-
WASHINGTON, D.C. — The American Association for Cancer Research (AACR) and the Kirk A. and Dorothy P. Landon Foundation will present three INNOVATOR Awards at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10. The Sixth Annual Landon Foundation-AACR INNOVATOR Award for Cancer Prevention...
Posted to
News
by
AACR News
on
Sat, Apr 6 2013
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Prevention Research, 2013 Annual Meeting, Dr.Carlos Gil Ferreira, Dr. Kenneth Y. Tsai, personalized cancer medicine, international collaboration, Landon INNOVATOR Awards, Dr. David P. Carbone, Dr. Nikhil Wagle
-
Levels of 13 genes elevated in unaffected breasts of women with hormone receptor-negative breast cancer. Eight of the genes were associated with lipid metabolism. Ability to identify those at risk may help tailor prevention strategies. PHILADELPHIA — The overexpression or underexpression of a newly...
Posted to
News
by
AACR News
on
Tue, Mar 19 2013
Filed under:
Filed under: Press Releases, Research, Treatment, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, prevention, Cancer Prevention Research, genetics, journal, hormone receptor-negative breast cancer, hormone receptor-positive breast cancer, breast cancer risk, Dr. Seema A. Khan, lipid metabolism
-
Loss of fat by surgical removal or a calorie-restricted diet reduced likelihood of developing intestinal tumors. Differences were found between male and female mice. Study emphasizes the need for strategies to reduce visceral fat. PHILADELPHIA — Visceral fat, or fat stored deep in the abdominal...
Posted to
News
by
AACR News
on
Wed, Mar 6 2013
Filed under:
Filed under: Press Releases, Research, Obesity, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, Cancer Prevention Research, journal, visceral fat, Dr. Derek M. Huffman, intestinal cancer
-
Expression of most microRNAs was similar between the two conditions. A small number were differentially expressed. These microRNAs could be biomarkers for early diagnosis of progression. PHILADELPHIA — A series of microRNA expression signatures that may help to define progression of the precancerous...
Posted to
News
by
AACR News
on
Wed, Mar 6 2013
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, Cancer Prevention Research, journal, microRNA, biomarkers, Esophageal Cancer, Barrett's esophagus, esophageal adenocarcinoma, Dr. Xifeng Wu
-
Profile test demonstrated high sensitivity and specificity. Test results could aid in clinical decision making. May provide a quick, affordable alternative to current genetic testing. PHILADELPHIA — A new multiple gene expression profile test was able to predict the presence of harmful BRCA1 or...
Posted to
News
by
AACR News
on
Tue, Jan 22 2013
Filed under:
Filed under: Press Releases, Research, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Prevention Research, women, journal, breast cancer risk, M.D., mutation, BRCA1, BRCA2, multiple gene expression profile test, Dr. Asher Y. Salmon
-
Patients with oral lesions can be grouped according to risk level. Two out of every three high-risk patients progressed to cancer. Follow-up and treatment could be tailored to a patient’s risk level. PHILADELPHIA — A group of molecular markers have been identified that can help clinicians...
Posted to
News
by
AACR News
on
Tue, Aug 21 2012
Filed under:
Filed under: Press Releases, Research, DNA, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, prevention, Cancer Prevention Research, journal, risk, oral cancer, Dr. Miriam Rosin
-
Agent acts against mTOR to prevent lesion progression. Oral cancer incidence reduced by 70 to 90 percent. Results are part of increasing evidence of metformin’s protective effect. PHILADELPHIA — New findings published in Cancer Prevention Research, a journal of the American Association...
Posted to
News
by
AACR News
on
Sat, Mar 31 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Prevention Research, meeting, 2012 Annual Meeting, AACR Annual Meeting 2012, Dr. J. Silvio Gutkind, oral cancer
-
Metformin activity occurs primarily in the liver. Drug is safe and well-tolerated in patients with diabetes. PHILADELPHIA — Metformin, a widely used, well-tolerated drug prescribed for patients with diabetes, may protect against liver cancer, according to a study published in Cancer Prevention...
Posted to
News
by
AACR News
on
Sat, Mar 31 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Prevention Research, meeting, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, liver cancer, Dr. Geoffrey Girnun, Metformin
-
Findings suggest the effects of food may be more complex. Adverse effect observed in younger women. PHILADELPHIA — Soy isoflavone supplements did not decrease breast cancer cell proliferation in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal...
Posted to
News
by
AACR News
on
Fri, Feb 3 2012
Filed under:
Filed under: Press Releases, Research, Breast Cancer, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, prevention, Cancer Prevention Research, women, journal, supplement, soy, Dr. Seema A. Khan, soy isoflavone
-
Melanoma risk was 60 percent higher among those not taking antiestrogen therapy. Researcher cautions against widespread antiestrogen supplementation use. Study included 7,360 women with breast cancer. PHILADELPHIA — Women with breast cancer who take antiestrogen supplements may be decreasing...
Posted to
News
by
AACR News
on
Wed, Jan 4 2012
Filed under:
Filed under: Press Releases, Research, Treatment, Breast Cancer, melanoma, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, prevention, Cancer Prevention Research, women, skin cancer, Dr. Christine Bouchardy, antiestrogen therapy, melanoma risk
-
Reductions of markers like PGE2 may be a biomarker for colon cancer prevention. Phase II study conducted in humans requires validation. Natural supplement use could be potential cancer prevention strategy. PHILADELPHIA — Ginger supplements reduced markers of colon inflammation in a select group of patients...
Posted to
News
by
AACR News
on
Tue, Oct 11 2011
Filed under:
Filed under: Press Releases, Research, inflammation, Media Materials, AACR, cancer prevention, American Association for Cancer Research, prevention, Cancer Prevention Research, National Cancer Institute, NCI, colon cancer, supplement, biomarker, ginger, naturopathic doctor, University of Michigan Medical School, ginger root, Dr. Suzanna M. Zick, PGE2, natural supplement
-
Tweet • Heavy alcohol users had a harder time adhering in the short term. • Cigarette smokers were less likely to maintain their regimen in the long term.• Obesity and physical activity were not associated with adherence. PHILADELPHIA...
Posted to
News
by
AACR News
on
Tue, Aug 23 2011
Filed under:
Filed under: Press Releases, adherence, Breast Cancer, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, tobacco, prevention, Cancer Prevention Research, smoking, women, National Cancer Institute, NCI, chemoprevention, NSABP, University of Pittsburgh, alcohol, National Surgical Adjuvant Breast and Bowel Project, Dr. Stephanie R. Land
-
Tweet • Agent lowered key biomarkers in lung cancer development. • Study confirms earlier research in Cancer Prevention Research. • Experts estimate former U.S. smoker population at 45 million. PHILADELPHIA — Celecoxib may emerge as a potent chemopreventive agent for lung cancer, according to...
Posted to
News
by
AACR News
on
Wed, Jul 6 2011
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, University of New Mexico, AACR, cancer prevention, lung cancer, American Association for Cancer Research, celecoxib, Ki-67 labeling index, tobacco, prevention, New Mexico VA Health System, Cancer Prevention Research, COX-2 inhibitor, smoking, Jenny Mao